Grant R. Whitman

763 citations

22 papers · 355 indexed · h-index 12

Co-authors: Ryan Choi Kayode K. Ojo Matthew A. Hulverson Wesley C. Van Voorhis Lynn K. Barrett Samuel L.M. Arnold Molly C. McCloskey Dustin J. Maly
Topics: Parasitic Infections and Diagnostics (15 papers)Pneumocystis jirovecii pneumonia detection and treatment (7 papers)Toxoplasma gondii Research Studies (6 papers)
Cited by: Parasitology Infectious Diseases Epidemiology
Journals: Journal of Clinical Microbiology Journal of Medicinal Chemistry The Journal of Infectious Diseases
Partner nations: United States Switzerland Spain

In The Last Decade

Grant R. Whitman

21 papers receiving 352 citations

Peers

Countries citing papers authored by Grant R. Whitman

Since Specialization

Citations

This map shows the geographic impact of Grant R. Whitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant R. Whitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant R. Whitman more than expected).

Fields of papers citing papers by Grant R. Whitman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant R. Whitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant R. Whitman. The network helps show where Grant R. Whitman may publish in the future.

Co-authorship network of co-authors of Grant R. Whitman

This figure shows the co-authorship network connecting the top 25 collaborators of Grant R. Whitman. A scholar is included among the top collaborators of Grant R. Whitman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant R. Whitman. Grant R. Whitman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pyridopyrimidinones as a new chemotype of calcium dependent protein kinase 1 (CDPK1) inhibitors for Cryptosporidium 2024 ·Molecular and Biochemical Parasitology ·(unknown),(unknown),Ryan Choi,Grant R. Whitman,Matthew A. Hulverson,(unknown),(unknown),Li Li,(unknown),(unknown),Case W. McNamara,Melissa S. Love,(unknown),Malina A. Bakowski,Ming Hu,Wesley C. Van Voorhis,Jan R. Mead,Gregory D. Cuny	1
2	Complementary Nonsputum Diagnostic Testing for Tuberculosis in People with HIV Using Oral Swab PCR and Urine Lipoarabinomannan Detection 2022 ·Journal of Clinical Microbiology ·Adrienne E. Shapiro,Alaina M. Olson,Lara Kidoguchi,(unknown),(unknown),(unknown),(unknown),Grant R. Whitman,Kris M. Weigel,Rachel C. Wood,(unknown),Paul K. Drain,Gerard A. Cangelosi	23
3	Accuracy of Tongue Swab Testing Using Xpert MTB-RIF Ultra for Tuberculosis Diagnosis 2022 ·Journal of Clinical Microbiology ·Alfred Andama,Grant R. Whitman,Rebecca Crowder,(unknown),Devan Jaganath,(unknown),(unknown),Fred C. Semitala,William Worodria,Catherine Cook,Rachel C. Wood,Kris M. Weigel,Alaina M. Olson,(unknown),Midori Kato‐Maeda,Claudia M. Denkinger,Payam Nahid,Gerard A. Cangelosi,Adithya Cattamanchi	38
4	Accuracy of Oral Swab Testing Using Xpert MTB-RIF Ultra for Tuberculosis Diagnosis 2022 ·Alfred Andama,(unknown),Devan Jaganath,(unknown),Fred C. Semitala,Eric Wobudeya,(unknown),(unknown),Grant R. Whitman,(unknown),Adithya Cattamanchi	0
5	In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts 2021 ·International Journal for Parasitology Drugs and Drug Resistance ·(unknown),Nicoleta Anghel,Pablo Winzer,Vreni Balmer,(unknown),(unknown),Ryan Choi,Matthew A. Hulverson,Grant R. Whitman,Samuel L.M. Arnold,Kayode K. Ojo,Wesley C. Van Voorhis,J. Stone Doggett,Luis Miguel Ortega‐Mora,Andrew Hemphill	23
6	Endochin-like quinolones (ELQs) and bumped kinase inhibitors (BKIs): Synergistic and additive effects of combined treatments against Neospora caninum infection in vitro and in vivo 2021 ·International Journal for Parasitology Drugs and Drug Resistance ·Nicoleta Anghel,(unknown),Pablo Winzer,Vreni Balmer,(unknown),(unknown),Ryan Choi,(unknown),Grant R. Whitman,Samuel L.M. Arnold,Kayode K. Ojo,Wesley C. Van Voorhis,J. Stone Doggett,Luis Miguel Ortega‐Mora,Andrew Hemphill	10
7	A short-term treatment with BKI-1294 does not protect foetuses from sheep experimentally infected with Neospora caninum tachyzoites during pregnancy 2021 ·International Journal for Parasitology Drugs and Drug Resistance ·Roberto Sánchez-Sánchez,Ignacio Ferre,Michela Re,(unknown),(unknown),(unknown),(unknown),L. M. Ferrer,Héctor Ruíz,(unknown),Júlio Benavides,(unknown),Ryan Choi,Grant R. Whitman,Andrew Hemphill,Wesley C. Van Voorhis,Luis Miguel Ortega‐Mora	9
8	Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis 2021 ·ACS Infectious Diseases ·Matthew A. Hulverson,Ryan Choi,Rama Subba Rao Vidadala,Grant R. Whitman,Vidadala V. Narayana,Kayode K. Ojo,Lynn K. Barrett,James J. Lynch,Kennan C. Marsh,Dale J. Kempf,Dustin J. Maly,Wesley C. Van Voorhis	6
9	Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice 2020 ·International Journal of Antimicrobial Agents ·Nicoleta Anghel,Pablo Winzer,(unknown),Joachim Müller,Xavier Langa,(unknown),Lynn K. Barrett,Rama Subba Rao Vidadala,Wenlin Huang,Ryan Choi,Matthew A. Hulverson,Grant R. Whitman,Samuel L.M. Arnold,Wesley C. Van Voorhis,Kayode K. Ojo,Dustin J. Maly,Erkang Fan,Andrew Hemphill	15
10	Reduced treatment frequencies with bumped kinase inhibitor 1369 are effective against porcine cystoisosporosis 2020 ·International Journal for Parasitology Drugs and Drug Resistance ·(unknown),Bärbel Ruttkowski,(unknown),Grant R. Whitman,Matthew A. Hulverson,Ryan Choi,(unknown),Kayode K. Ojo,Wesley C. Van Voorhis,Anja Joachim	2
11	Bumped kinase inhibitor 1369 is effective against Cystoisospora suis in vivo and in vitro 2019 ·International Journal for Parasitology Drugs and Drug Resistance ·(unknown),Kayode K. Ojo,(unknown),Bärbel Ruttkowski,Rama Subba Rao Vidadala,(unknown),(unknown),Grant R. Whitman,(unknown),Lynn K. Barrett,Matthew A. Hulverson,Ryan Choi,(unknown),Dustin J. Maly,Andrew Hemphill,Wesley C. Van Voorhis,Anja Joachim	10
12	Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy 2019 ·Antimicrobial Agents and Chemotherapy ·Roberto Sánchez-Sánchez,Ignacio Ferre,Michela Re,Juan José Ramos,Javier Regidor‐Cerrillo,(unknown),(unknown),(unknown),Júlio Benavides,Andrew Hemphill,Matthew A. Hulverson,Lynn K. Barrett,Ryan Choi,Grant R. Whitman,Kayode K. Ojo,Wesley C. Van Voorhis,Luis Miguel Ortega‐Mora	21
13	Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy 2019 ·Journal of Medicinal Chemistry ·Wenlin Huang,Matthew A. Hulverson,Ryan Choi,Samuel L.M. Arnold,Zhongsheng Zhang,Molly C. McCloskey,Grant R. Whitman,Robert C. Hackman,Kasey Rivas,Lynn K. Barrett,Kayode K. Ojo,Wesley C. Van Voorhis,Erkang Fan	23
14	Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis 2018 ·Antimicrobial Agents and Chemotherapy ·Sangun Lee,(unknown),Gillian Beamer,(unknown),(unknown),(unknown),Minhee Lee,Matthew A. Hulverson,Ryan Choi,Grant R. Whitman,Kayode K. Ojo,Samuel L.M. Arnold,Wesley C. Van Voorhis,Saul Tzipori	31
15	7H-Pyrrolo[2,3-d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1H-Pyrazolo[3,4-d]pyrimidin-4-amine-Based Inhibitors 2018 ·ACS Infectious Diseases ·Rama Subba Rao Vidadala,Martin Golkowski,Matthew A. Hulverson,Ryan Choi,Molly C. McCloskey,Grant R. Whitman,Wenlin Huang,Samuel L.M. Arnold,Lynn K. Barrett,Erkang Fan,E.A. Merritt,Wesley C. Van Voorhis,Kayode K. Ojo,Dustin J. Maly	4
16	Screening of the Pathogen Box for inhibitors with dual efficacy against Giardia lamblia and Cryptosporidium parvum 2018 ·PLoS neglected tropical diseases ·Kelly M. Hennessey,(unknown),(unknown),Matthew A. Hulverson,Ryan Choi,Molly C. McCloskey,Grant R. Whitman,Lynn K. Barrett,E.A. Merritt,Alexander R. Paredez,Kayode K. Ojo	31
17	Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis 2018 ·The Journal of Infectious Diseases ·Matthew A. Hulverson,Igor Bruzual,(unknown),Wenlin Huang,Rama Subba Rao Vidadala,Ryan Choi,Samuel L.M. Arnold,Grant R. Whitman,Molly C. McCloskey,Lynn K. Barrett,Kasey Rivas,(unknown),Amy E. DeRocher,Marilyn Parsons,Kayode K. Ojo,Dustin J. Maly,Erkang Fan,Wesley C. Van Voorhis,J. Stone Doggett	11
18	Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy 2017 ·The Journal of Infectious Diseases ·Matthew A. Hulverson,Sumiti Vinayak,Ryan Choi,Deborah A. Schaefer,Alejandro Castellanos-González,Rama Subba Rao Vidadala,Carrie F. Brooks,Gillian T. Herbert,(unknown),Grant R. Whitman,(unknown),Samuel L.M. Arnold,Kasey Rivas,Lynn K. Barrett,A. Clinton White,Dustin J. Maly,Michael W. Riggs,Boris Striepen,Wesley C. Van Voorhis,Kayode K. Ojo	43
19	5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum 2017 ·Antimicrobial Agents and Chemotherapy ·Wenlin Huang,Ryan Choi,Matthew A. Hulverson,Zhongsheng Zhang,Molly C. McCloskey,Deborah A. Schaefer,Grant R. Whitman,Lynn K. Barrett,Rama Subba Rao Vidadala,Michael W. Riggs,Dustin J. Maly,Wesley C. Van Voorhis,Kayode K. Ojo,Erkang Fan	12
20	Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection 2017 ·The Journal of Infectious Diseases ·Samuel L.M. Arnold,Ryan Choi,Matthew A. Hulverson,Deborah A. Schaefer,Sumiti Vinayak,Rama Subba Rao Vidadala,Molly C. McCloskey,Grant R. Whitman,Wenlin Huang,Lynn K. Barrett,Kayode K. Ojo,Erkang Fan,Dustin J. Maly,Michael W. Riggs,Boris Striepen,Wesley C. Van Voorhis	33

About Grant R. Whitman

Grant R. Whitman is a scholar working on Parasitology, Infectious Diseases and Epidemiology, having authored 22 papers that have together received 355 indexed citations. Recurring topics across this work include Parasitic Infections and Diagnostics (15 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and Toxoplasma gondii Research Studies (6 papers). The work is most often cited by research in Parasitology (251 citations), Infectious Diseases (138 citations) and Epidemiology (150 citations). Grant R. Whitman has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include Ryan Choi, Kayode K. Ojo, Matthew A. Hulverson, Wesley C. Van Voorhis, Lynn K. Barrett, Samuel L.M. Arnold, Molly C. McCloskey, Dustin J. Maly, Rama Subba Rao Vidadala and Erkang Fan. Their work appears in journals such as Journal of Clinical Microbiology, Journal of Medicinal Chemistry and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact